Aldeyra Therapeutics Announces Positive Results from Phase 2b

60
ALDX : Aldeyra Therapeutics, Inc.
2018-09-26 07:00:00
Aldeyra Therapeutics Announces Positive Results from Phase 2b Dry Eye Disease Clinical Trial

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.